
Independent Clinical Cancer Research in the Continuum of Drug Development into Access – for Patient-Centred Cancer Treatment & Care
12 Jan 2022

KEYTRUDA® (pembrolizumab) Showed Statistically Significant Improvement in Disease-Free Survival Versus Placebo as Adjuvant Treatment for Patients With Stage IB-IIIA Non-Small Cell Lung Cancer Regardless of PD-L1 Expression
10 Jan 2022

EHDS: an opportunity to unleash the power of data?
15 Dec 2021

Save and improve citizens’ lives across Europe by continuing vital EU-UK research collaboration
14 Dec 2021

Opportunity with Neoplasia journal – Commissioning Editor Oncology (call for applications)
8 Dec 2021

Results from monotherapy group in UPSTREAM demonstrate trial’s feasibility in head and neck squamous cell carcinoma
23 Nov 2021

EORTC TOLERANCE trial in elderly patients with advanced soft tissue sarcoma receives support from Rising Tide Foundation
17 Nov 2021

Prof. Dr. A.T. van Oosterom (EORTC President 2000-2003)
10 Nov 2021